M. Warner

Hantavirus serologies in patients hospitalized with community-acquired pneumonia.

R. Moore, P. Auwaerter, L. Mundy, 1996, The Journal of infectious diseases.

Diagnosis of Chlamydia pneumoniae infection in patients with community-acquired pneumonia by polymerase chain reaction enzyme immunoassay.

T. Quinn, C. Gaydos, P. Auwaerter, 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Diffuse Alveolar Hemorrhage and Systemic Lupus Erythematosus: Clinical Presentation, Histology, Survival, and Outcome

M. Zamora, R. Tuder, M. Schwarz, 1997, Medicine.

Molecular Adjuvant Adenosine Deaminase-1 Immunity following Coimmunization with Improved Durability to SARS-CoV-2 Vaccine

Emma A. Gordon, M. Kutzler, I. Chaiken, 2022 .

Duration of protection and humoral immunity induced by an adenovirus-vectored subunit vaccine for foot-and-mouth disease (FMD) in Holstein steers.

M. Larocco, J. Palarea‐Albaladejo, J. Pacheco, 2019, Vaccine.

Community‐Acquired Pneumonia: Impact of Immune Status

J. Bartlett, T. Quinn, C. Gaydos, 1996, American journal of respiratory and critical care medicine.

Mutation and expression analysis of the endoglin gene in hereditary hemorrhagic telangiectasia reveals null alleles

Joshua D. Smith, A. Guttmacher, W. Craigen, 1998, Human mutation.

Community-acquired pneumonia: impact of immune status.

Richard D Moore, R. Moore, P. Auwaerter, 1995 .

The effect of decreasing amounts of live virus, while antigen content remains constant, on immunogenicity of Oka/Merck varicella vaccine.

B. Watson, B. Kuter, S. Starr, 1993, The Journal of infectious diseases.